尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Saran Atul, Vice-Président Exécutif, Développement Corporatif, Conseiller Général et Secrétaire. Director active across 1 company, notably Emergent BioSolutions Inc.. Cumulatively, 6 disclosures have been published. History available since 22 February 2022. The latest transaction was disclosed on 28 February 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
SARAN ATUL is Vice-President Executive, Corporate Development, General Counsel and Secretary. He has 6 filings in total, and the 6 sampled filings concern Emergent BioSolutions Inc., with transactions of tax withholding nature between 2022-02-24 and 2023-03-02; sum_buy_eur and sum_sell_eur are 0.